Cargando…

Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment

PURPOSE: Ciprofloxacin (CIP) has poor lung targeting after oral inhalation. This study developed optimized inhalable nanostructured lipid carriers (NLCs) for CIP to enhance deposition and accumulation in deeper parts of the lungs for treatment of noncystic fibrosis bronchiectasis (NCFB). METHODS: NL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almurshedi, Alanood S, Aljunaidel, Hessah A, Alquadeib, Bushra, Aldosari, Basmah N, Alfagih, Iman M, Almarshidy, Salma S, Eltahir, Eram K D, Mohamoud, Amany Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012696/ https://www.ncbi.nlm.nih.gov/pubmed/33814907 http://dx.doi.org/10.2147/IJN.S286896

Ejemplares similares

Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
por: Alfagih, Iman M., et al.
Publicado: (2020)

Development and Validation of a Simple and Sensitive LC-MS/MS Method for Quantification of Metformin in Dried Blood Spot Its Application as an Indicator for Medication Adherence
por: ALquadeib, Bushra T, et al.
Publicado: (2021)

New investigation of anti-inflammatory activity of Polycladia crinita and biosynthesized selenium nanoparticles: isolation and characterization
por: Almurshedi, Alanood S., et al.
Publicado: (2023)

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
por: Aldosari, Basmah N., et al.
Publicado: (2021)

The Role of Macrolides in Noncystic Fibrosis Bronchiectasis
por: Figueiredo, Bruna de Campos Guimarães e, et al.
Publicado: (2011)

Noncystic fibrosis bronchiectasis: Is it an orphan disease?
por: Mobaireek, Khalid F.
Publicado: (2007)

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015)

Gastro-Oesophageal Reflux in Noncystic Fibrosis Bronchiectasis
por: Lee, Annemarie L., et al.
Publicado: (2011)

A neglected problem of developing countries: Noncystic fibrosis bronchiectasis
por: Babayigit, Arzu, et al.
Publicado: (2009)

Quality of life and its determinants in patients with noncystic fibrosis bronchiectasis
por: Sami, Ramin, et al.
Publicado: (2021)

Noninvasive Ventilation for Acute Respiratory Failure due to Noncystic Fibrosis Bronchiectasis
por: Hadda, Vijay, et al.
Publicado: (2018)

Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013
por: Weycker, Derek, et al.
Publicado: (2017)

Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review
por: Máiz Carro, Luis, et al.
Publicado: (2019)

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis
por: Al-Jahdali, Hamdan, et al.
Publicado: (2017)

Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis
por: Lommatzsch, Sherstin T.
Publicado: (2020)

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016)

Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis
por: Dente, Federico L., et al.
Publicado: (2015)

Total oxidant and antioxidant status and paraoxonase 1 levels ofchildren with noncystic fibrosis bronchiectasis
por: GEDİK, Ahmet Hakan, et al.
Publicado: (2020)

A Novel Sustained Anti-Inflammatory Effect of Atorvastatin—Calcium PLGA Nanoparticles: In Vitro Optimization and In Vivo Evaluation
por: Abdelkader, Dalia H., et al.
Publicado: (2021)

The Oral Administration of Lidocaine HCl Biodegradable Microspheres: Formulation and Optimization
por: ALQuadeib, Bushra T, et al.
Publicado: (2020)

Zinc Oxide Nanoparticles as Potential Delivery Carrier: Green Synthesis by Aspergillus niger Endophytic Fungus, Characterization, and In Vitro/In Vivo Antibacterial Activity
por: Abdelkader, Dalia H., et al.
Publicado: (2022)

A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center
por: Banjar, Hanaa Hasan
Publicado: (2007)

Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis
por: Wang, Donghai, et al.
Publicado: (2019)

Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis
por: Zhang, Kaijun, et al.
Publicado: (2022)

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
por: Chorepsima, Stamatia, et al.
Publicado: (2018)

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
Publicado: (2017)

Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines
por: Zaki, Randa Mohammed, et al.
Publicado: (2023)

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis
por: Maughan, Heather, et al.
Publicado: (2012)

Effect of Low-Dose, Long-Term Roxithromycin on Airway Inflammation and Remodeling of Stable Noncystic Fibrosis Bronchiectasis
por: Liu, Jifeng, et al.
Publicado: (2014)

Which scoring system is better in association with exercise capacity and health status in noncystic fibrosis bronchiectasis patients?
por: VAROL, Yelda, et al.
Publicado: (2021)

Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review
por: Miao, Xia-Yi, et al.
Publicado: (2015)

Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast Cancer Cell Line
por: Zaki, Randa Mohammed, et al.
Publicado: (2023)

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
por: Wilson, Robert, et al.
Publicado: (2013)

Effects of exercise on secretion transport, inflammation, and quality of life in patients with noncystic fibrosis bronchiectasis: Protocol for a randomized controlled trial
por: dos Santos, Daniele Oliveira, et al.
Publicado: (2018)

Pharmaceutical evaluation of different shampoo brands in local Saudi market
por: AlQuadeib, Bushra T., et al.
Publicado: (2018)

Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials
por: Lim, Jeong Uk, et al.
Publicado: (2019)

A retrospective correlative profiling of lung functions, microbiological, radiological, periodontal, hematological parameters in noncystic fibrosis bronchiectasis patients of North India
por: Gupta, Abhaya, et al.
Publicado: (2022)

The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography
por: Gürel, Emre, et al.
Publicado: (2023)

Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment
por: Zaki, Randa Mohammed, et al.
Publicado: (2022)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
por: Martinez-Garcia, Miguel Angel
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_32husluh4r5oe27i0rq4dd8rnb